BofA Securities Reiterates Buy Rating on Medtronic (MDT) on 'Strong Affera CE mark Data'
Tweet Send to a Friend
BofA Securities analyst Travis Steed reiterated a Buy rating and $100.00 price target on Medtronic, Inc. (NYSE: MDT) amid strong ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
